| CAS ID: | 67416-61-9 |
| Molecular Formula: | C32H48O5 |
| Molecular Weight: | 512.7 g/mol |
| Monoisotopic Mass: | 512.3502 g/mol |
| Class: | Small Molecule |
| Natural Product: | Yes |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C32H48O5/c1-18-9-12-28(4)15-16-30(6)21(25(28)19(18)2)17-22(34)26-29(5)13-11-24(37-20(3)33)32(8,27(35)36)23(29)10-14-31(26,30)7/h17-19,23-26H,9-16H2,1-8H3,(H,35,36)/t18-,19+,23-,24-,25+,26-,28-,29+,30-,31-,32-/m1/s1 | See All |
| InChI Key: | HMMGKOVEOFBCAU-BCDBGHSCSA-N | |
| Smiles: | C[C@@H]1CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@@H](OC(=O)C)[C@@](C)([C@@H]5CC[C@@]34C)C(=O)O)[C@@H]2[C@H]1C | See All |
| Molfile: | Download |
Reference Record 1
| PubMed ID | 28005559 | Target ID | |
| Uniprot ID | Name | ||
| Model | rat | Fibrosis Disease | Fibrosis |
| Process I | |||
| Process II | fibroblasts proliferation,fibroblasts migration | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting TGF-β1/Smad3 pathway | ||
Reference Record 2
| PubMed ID | 24140598 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSCs proliferation | ||
| Process III | |||
| Mechanism | |||
| PubChem: | 11168203 |
| ChEMBL: | CHEMBL237111 |